Integrated Wealth Concepts LLC Ardelyx, Inc. Transaction History

Integrated Wealth Concepts LLC

  • $7.83 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$3.29 - $6.64 $3,224 - $6,507
980 Added 9.03%
11,830 $73,000
Q3 2023

Nov 15, 2023
SELL
$3.3 - $4.83 $3,795 - $5,554
-1,150 Reduced 9.58%
10,850 $44,000
Q1 2023

May 03, 2023
SELL
$2.68 - $4.79 $9,648 - $17,244
-3,600 Reduced 23.08%
12,000 $57,000
Q4 2022

Feb 13, 2023
BUY
$1.22 - $2.85 $19,032 - $44,460
15,600 New
15,600 $44,000
Q1 2022

May 12, 2022
BUY
$0.65 - $1.18 $6,500 - $11,800
10,000 New
10,000 $11,000

Others Institutions Holding ARDX

# of Institutions
219
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $815M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email